Jun 12, 2020
FDA Approves Drug to Treat Infants and Children with HIV
May 22, 2020
Global Antiretroviral Therapy Market (NRTI, NNRTI, Protease Inhibitors & Integrase Inhibitors): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
May 14, 2020
Technological Advances in the Anti-Viral Drug Therapy Market to Aid Treatment of COVID-19 Patients, Reports TBRC
May 04, 2020
Viriom Announces Initiation of Phase 2 Study Investigating Efficacy of Intramuscular Long-Acting Injectable Nanoformulation of VM1500A in HIV-Infected Patients
Apr 13, 2020
Ascletis Receives IND Approval for its HIV Drug ASC09F
Apr 08, 2020
Viriom Initiates Phase 2 Clinical Study of Elsulfavirine for Treatment of COVID-19
Jan 13, 2020
Breakthrough ID-Cap System from etectRx(TM) Selected to Measure Adherence to HIV Treatment in New University of Colorado Study
Dec 03, 2019
Viriom Launches Reproductive Toxicity Studies for Elpida® (Elsulfavirine) Once Weekly Oral Formulation
Nov 05, 2019
FDA authorizes marketing of first next-generation sequencing test for detecting HIV-1 drug resistance mutations
Oct 08, 2019
Clinicians Not Consistent With Guidelines When Managing HIV/HCV Coinfection
Oct 07, 2019
Clinician Choices Often Differ From Those of Experts When Switching HIV Treatment in Patients With Virologic Suppression
Sep 30, 2019
Celltrion to Launch TemixysTM Double Combination Once-Daily Tablet for HIV Treatment in the U.S.
Sep 26, 2019
GT Biopharma Announces HIV Trike(TM) Data to be Published
Sep 03, 2019
Viriom announces NIH/NIAID and Division of AIDS Collaboration with the Long-Acting/Extended Release Antiviral Resource Program
Sep 03, 2019
US HIV Market and Competitive Landscape 2019-2024: Treatments, Pipeline, Epidemiology, Marketed Drugs, Size, Sales, Competitive Landscape
Jul 02, 2019
Viriom Signed Licensing Agreement for Indonesia with P.T. Lloyd Pharma
Jun 19, 2019
Global HIV Disease Coverage Forecast and Market 2019-2024: B/F/TAF will Drive Significant Revenue Growth Due to its Attractive Combination of an INSTI and a Preferred Backbone
Apr 29, 2019
Janssen Announces Submission of New Drug Application to U.S. FDA For the First Monthly, Injectable, Two-Drug Regimen of Rilpivirine and Cabotegravir for Treatment of HIV
Apr 17, 2019
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
Apr 17, 2019
Global Antiretroviral Market is projected to display a robust growth represented by a CAGR of 4.70% during 2018 - 2023